Listed by the USPTO as BRADLEY, CHRISTINA
Tech Center 1600 • Art Units: 1654 1675
This examiner grants 63% of resolved cases
BRADLEY, CHRISTINA works in Tech Center 1600 and art unit 1654, with 1040 resolved cases. The allowance rate is 62.6%, while the median time to allowance is 986 days. The interview lift is 33.3%, making interview practice a material consideration in this record.
The listed companies are Novo Nordisk A/S, The Johns Hopkins University, and Xygenyx Inc. The listed firms are Maschoff Brennan, MH2 TECHNOLOGY LAW GROUP, LLP, and SUGHRUE MION, PLLC. The combination of a substantial case history and a meaningful interview lift supports evaluating examiner interviews alongside claim amendments and written responses.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17920698 | INHIBITION OF SARS-COV-2 VIRAL ENTRY THROUGH ORAL ADMINISTRATION OF LACTOFERRIN AND USES THEREOF | Non-Final OA | The Regents of the University of Michigan |
| 18551557 | K-RAS INHIBITOR | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18253084 | MEMBRANE-ACTIVE PEPTIDES AND METHODS FOR REVERSIBLE BLOOD- BRAIN BARRIER OPENING | Final Rejection | THE JOHNS HOPKINS UNIVERSITY |
| 18559251 | PURIFICATION OF SPECIFIC TRIPEPTIDE BY ACIDIFICATION | Non-Final OA | DSM IP Assets B.V. |
| 18556402 | SMALL HYDROPHOBIC PROTEIN DRUG CONJUGATES AND USES THEREOF | Non-Final OA | DANMARKS TEKNISKE UNIVERSITET |
| 17759636 | ALLERGEN PROTECTION AGAINST URUSHIOLS | Non-Final OA | BEIERSDORF AG |
| 18550859 | METHODS OF TREATING NEURODEGENERATIVE DISORDERS WITH INTRANASAL NF-KAPPAB ESSENTIAL MODIFIER (NEMO)-BINDING DOMAIN (NBD) PEPTIDE | Non-Final OA | Rush University Medical Center |
| 18850815 | PEPTIDE HAVING ANTI-INFLAMMATORY AND ANTI-FIBROTIC ACTIVITIES AND USE THEREOF | Non-Final OA | CAREGEN CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy62.6% of resolved applications examined by Christina Bradley were allowed (1,040 resolved cases), compared with 48.5% across Art Unit 1654 over the last five years.
This examiner's interview lift is +33.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Christina Bradley took 986 days on average from filing to allowance.
Christina Bradley examines applications in Art Unit 1654 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
